LONG-TERM ADMINISTRATION OF PRAVASTATIN, A POTENT HMG-COA REDUCTASE INHIBITOR, PROLONGS SURVIVAL OF PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA - A RANDOMIZED CONTROLLED TRIAL

Authors
KAWATA S YAMASAKI E NAGASE T MATSUDA Y TAMURA S IMAI Y MATSUZAWA Y
Citation
S. Kawata et al., LONG-TERM ADMINISTRATION OF PRAVASTATIN, A POTENT HMG-COA REDUCTASE INHIBITOR, PROLONGS SURVIVAL OF PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA - A RANDOMIZED CONTROLLED TRIAL, Hepatology, 24(4), 1996, pp. 476-476
Citations number
NO
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
Hepatology → ACNP
ISSN journal
02709139
Volume
24
Issue
4
Year of publication
1996
Part
2
Supplement
S
Pages
476 - 476
Database
ISI
SICI code
0270-9139(1996)24:4<476:LAOPAP>2.0.ZU;2-4